Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Safety Shot Inc SHOT

Safety Shot, Inc. is a wellness and functional beverage company. The Company is launching its Safety Shot, a patented beverage, which reduces blood alcohol content and boosting clarity. Safety Shot is an over-the-counter drink that can lower blood alcohol content to allow recovery from the effects of alcohol at a rate faster than would occur normally. Its product pipeline includes a range of... see more

Recent & Breaking News (NDAQ:SHOT)

SRM Entertainment Announces Licensing Agreement with Toonz Media Group and Zoonicorn LLC for Pre-School Brand Zoonicorn

Accesswire August 17, 2022

Jupiter Wellness Reports Second Quarter 2022 Financial Results and Operational Highlights

Accesswire August 16, 2022

SRM Entertainment Announces Multi-Year SMURFS License

Accesswire August 11, 2022

Jupiter Wellness Announces Repayment Agreement with Benuvia, Inc., Formally Next Frontier Pharmaceuticals

Accesswire July 26, 2022

CORRECTION FROM SOURCE: Jupiter Wellness Developing Novel Women's Sexual Health Product

Accesswire July 6, 2022

Jupiter Wellness Developing Novel Women's Sexual Health Product

Accesswire July 6, 2022

Jupiter Wellness Expands Distribution in Asia and the Middle East with Newly Acquired Minoxidil (Rogaine(R)) and Photoci(TM) Products

Accesswire June 28, 2022

Jupiter Wellness Licenses Minoxidil Booster to Taisho

Accesswire June 23, 2022

Dr. Andy Goren and Dr. John McCoy Appointed to Senior Scientific Positions at Jupiter Wellness

Accesswire June 22, 2022

Jupiter Wellness Acquires the Assets of Applied Biology Inc., a Leading Biotechnology Company Specializing in Hair and Skin Science

Accesswire June 21, 2022

Jupiter Wellness Announces the Retirement of Approximately 10% of its Outstanding Shares

Accesswire June 17, 2022

Paul Jones Appointed as Senior Project Manager at Jupiter Wellness

Accesswire June 2, 2022

Jupiter Wellness' to Present JW-300 Topical Burn Treatment at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference

Accesswire May 4, 2022

Jupiter Wellness to Offer Clinical Research Services with Acquisition of Ascent Clinical Research: $3 Million Annual Revenue & EBITDA Contribution to Jupiter

Accesswire April 27, 2022

Jupiter Wellness Appoints E-Commerce & Marketing Team to Drive Sales of its Growing Portfolio of Proprietary Health and Wellness Brands

Accesswire April 18, 2022

Jupiter Wellness to Launch CaniSun for Shark Defense Sunscreen with Patented Shark Repellents

Accesswire April 7, 2022

Article "Novel Cannabidiol Aspartame Combination Treatment (JW-100) Significantly Reduces ISGA Score in Atopic Dermatitis: Results From a Randomized Double-Blinded Placebo-Controlled Interventional Study" Published in Journal of Cosmetic Dermatology

Accesswire April 6, 2022

Jupiter Wellness Launches NoStingz Jellyfish Protective Sunscreen Backed by Patent-Pending Formula in $13 B Sunscreen Market

Accesswire April 5, 2022

Jupiter Wellness Completes Enrollment in Double-Blind Placebo-Controlled Clinical Trial of JW-200 for the Treatment of Actinic Keratosis

Accesswire February 18, 2022

Jupiter Wellness Merger Partner Next Frontier's Executive Chairman Shannon Soqui Interview with Benzinga

Accesswire February 15, 2022